Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
Ann Intern Med
.
2022 Feb;175(2):W14.
doi: 10.7326/L21-0730.
Authors
Philippe Brouillard
1
,
Jacques LeLorier
1
Affiliation
1
Université de Montréal, Montreal, Quebec, Canada.
PMID:
35157813
DOI:
10.7326/L21-0730
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants / adverse effects
Hemorrhage / chemically induced
Humans
Venous Thromboembolism* / drug therapy
Substances
Anticoagulants